B-Flexion Life Sciences

B-Flexion Life Sciences is a Boston-based investment firm classified in the source data as venture but operating at growth stage. Its focus is on emerging life sciences and biotech enterprises, including life sciences tools and pharma or therapeutics platforms. The firm is entrepreneurial in style, often partnering closely with founders rather than running traditional buyout playbooks. AI is not noted as a dedicated focus area.

Check sizes range from $5M to $25M, with US-centered deployment. The firm engages at growth stage, typically once a company has technical validation and is approaching commercial inflection. The source data does not list specific named portfolio companies in the healthcare AI subset.

For healthcare AI founders, B-Flexion is relevant only if the work sits squarely in life sciences tools, biotech, or therapeutics, particularly platforms where AI is embedded in drug discovery, lab tooling, or assay design. Pure clinical software founders are not the target. Approach when the platform has clear scientific traction and a defined commercial path.